It was noted that RNA-containing viruses change very rapidly so it is necessary to have technologies that allow to switch from one antigen variant to another
Gamaleya Center has technologies for developing vaccines if new COVID-19 strains emerge
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться